Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Not Confirmed
Not Confirmed
11-13 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Industry Trade Show
Not Confirmed
11-13 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/medical-breakthroughs-in-2024-alzheimer-s-schizophrenia-copd-mash-see-pathbreaking-treatments
17 Aug 2022
// HEALTH ECONOMICS TIMES
https://health.economictimes.indiatimes.com/news/pharma/pharma-inc-sets-sights-on-monkeypox-vax/93603964
27 Aug 2021
// PHARMABIZ
05 Oct 2020
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/medicure-announces-an-agreement-with-reliance-life-sciences-for-the-marketing-rights-of-a-cardiovascular-biosimilar-301145432.html
19 Aug 2020
// ECONOMICTIMES
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/netmeds-to-complement-rils-digital-consultation-diagnostic-test-offering-say-analysts/articleshow/77633215.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
26 Jul 2016
// ECONOMIC TIMES
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/reliance-life-gains-global-rights-for-copies-of-infliximab/articleshow/53389127.cms
04 Jun 2016
// Prabha Raghavan ECONOMIC TIMES
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/reliance-life-sciences-appeals-marketing-restrictions-on-breast-cancer-drug/articleshow/52573871.cms
Inspections and registrations
ABOUT THIS PAGE
Reliance Life Sciences Private Limited is a supplier offers 17 products (APIs, Excipients or Intermediates).
Find a price of Bortezomib bulk with DMF, WC offered by Reliance Life Sciences Private Limited
Find a price of Capecitabine bulk with DMF, WC offered by Reliance Life Sciences Private Limited
Find a price of Dasatinib bulk with DMF, WC offered by Reliance Life Sciences Private Limited
Find a price of Decitabine bulk with DMF, WC offered by Reliance Life Sciences Private Limited
Find a price of Erlotinib Hydrochloride bulk with DMF, WC offered by Reliance Life Sciences Private Limited
Find a price of Imatinib Mesylate bulk with DMF, WC offered by Reliance Life Sciences Private Limited
Find a price of Lenalidomide bulk with DMF, WC offered by Reliance Life Sciences Private Limited
Find a price of Pemetrexed Disodium bulk with DMF, WC offered by Reliance Life Sciences Private Limited
Find a price of Sorafenib bulk with DMF, WC offered by Reliance Life Sciences Private Limited
Find a price of Sunitinib bulk with DMF, WC offered by Reliance Life Sciences Private Limited
Find a price of Temozolomide bulk with DMF, WC offered by Reliance Life Sciences Private Limited
Find a price of Azacitidine bulk with DMF offered by Reliance Life Sciences Private Limited
Find a price of Dutasteride bulk offered by Reliance Life Sciences Private Limited
Find a price of Eszopiclone bulk offered by Reliance Life Sciences Private Limited
Find a price of Loteprednol Etabonate bulk offered by Reliance Life Sciences Private Limited
Find a price of Nandrolone Decanoate bulk offered by Reliance Life Sciences Private Limited
Find a price of Rocuronium Bromide bulk offered by Reliance Life Sciences Private Limited
LOOKING FOR A SUPPLIER?